Recordati Rare Diseases North America
Mick Munafo is a seasoned professional in the rare disease sector, currently serving as the Rare Disease Strategic Account Director at Recordati Rare Diseases North America since December 2020. Previously, Mick held notable roles at Takeda and Shire, where responsibilities included educating healthcare providers and identifying patients with rare diseases, specifically Hypoparathyroidism, across a wide geographic area. Mick's career began at Novo Nordisk, with progressive positions leading to the leadership team, where strategic planning and performance milestones were key focuses. Throughout the career, Mick has been recognized with multiple Circle of Excellence Awards for outstanding performance in territory management and disease-state education. Mick holds a degree from Wright State University.
This person is not in any offices
Recordati Rare Diseases North America
1 followers
Recordati Rare Diseases Inc. (RRD) markets products to treat rare diseases. RRD is a member of the Recordati Group, which includes Recordati S.p.A., Orphan Europe, among other companies around the globe. The Recordati Group, which was established in 1926 currently employs more than 4,000 worldwide. The RRD mission is to reduce the impact of extremely rare and devastating diseases by providing urgently needed therapies. We work side-by-side with rare disease communities to increase awareness, improve diagnosis and expand availability of treatments for people with rare diseases.